EGFR and non-small cell lung carcinoma: One possible explanation involves the tumor microenvironment (TME) in NSCLC with certain genetic alterations, such as EGFR or ALK, which have been associated with reduced immunogenicity and often exhibit lower tumor mutational burden (TMB) and decreased neoantigen load [15, 16].